VRTXVertex Pharmaceuticals Incorporated

$125B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4.2B+36.6% YoY

Gross Profit

$3.6B86.8% margin

Operating Income

$1.2B28.8% margin

Net Income

$1.2B28.3% margin

EPS (Diluted)

$4.51

Cash Flow

Operating Cash Flow

$1.6B

Free Cash Flow

$1.5B

Stock-Based Comp.

$360M

Balance Sheet

Total Assets

$8.3B

Total Liabilities

$2.2B

Stockholders' Equity

$6.1B

Cash & Equivalents

$3.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.2B	$3.0B	+36.6%
Gross Profit	$3.6B	$2.6B	+37.0%
Operating Income	$1.2B	$635M	+88.5%
Net Income	$1.2B	$2.1B	-43.9%

VRTX FY 2019 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena